Parameters

All patients

IDH

Control

Number

93

21

72

Age (years)

48.72 ± 14.06

49.14 ± 13.21

48.6 ± 14.39

Gender: Male

51 (54.8%)

14 (66.7%)

37 (51.4%)

Female

42 (45.2%)

7 (33.3%)

35 (48.6%)

Duration in dialysis (months)

64.22 ± 45.63

51.38 ± 39.8

67.96 ± 46.79

Hypertensive nephropathy

36 (38.7%)

11 (52.4%)

25 (34.7%)

Glomerulonephritis

20 (21.5%)

3 (14.3%)

17 (22.2%)

Unknown Nephropathy

19 (20.4%)

3 (14.3%)

16 (22.2%)

Dry weight (Kg)

62.71 ± 13.69

59.19 ± 11.26

63.73 ± 14.23

IDWG (Kg)

2.04 ± 1.06

1.86 ± 1.22

2.09 ± 1.01

Arteriovenous Fistula

64 (68.8%)

14 (66.7%)

50 (69.4%)

Single catheter

10 (10.8%)

2 (9.5%)

8 (11.1%)

tunneled catheter

19 (20.4%)

5 (23.8%)

14 (19.4%)

Mean BMI (Kg/m²)

21.36 ± 4.26

20 ± 3.73

21.72 ± 4.34

Residual Diuresis

42 (45.2%)

11 (52.4%)

31 (43.1%)

Intradialytic hypotension

11 (11.8%)

0

11 (15.3%)

Anemia

57 (68.7%)

14 (73.7%)

43 (67.2%)

Hemoglobin (g/dl)

9.27 ± 1.91

9.08 ± 1.69

9.33 ± 1.98

Serum albumin (g/l)

35.4 ± 7.48

32.67 ± 5.87

36.44 ± 7.86

Hypoalbuminemia

18 (50%)

7 (33.3%)

10 (13.9%)

Serum calcium (mg/l)

88.71 ± 6.18

90.99 ± 5

88.07 ± 6.37

Serum phosphate (mg/l)

36.22 ± 12.03

37.43 ± 9.84

35.9 ± 12.6

PTH (ng/l)

745.91 ± 593.49

734.49 ± 590.37

749.18 ± 602.92

LVH (ECG)

29 (53.8%)

5 (23.8%)

24 (33.3%)

LVH (TTE)

7 (13.2%)

2 (9.5%)

10 (13.9%)

ESA

19 (20.4%)

2 (9.5%)

17 (23.6%)

Iron treatment

15 (16.1%)

2 (9.5%)

13 (18.1%)

Calcium treatment

39 (42.4%)

7 (33.3%)

32 (45.1%)